Alnylam Pharmaceuticals
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Alnylam Pharmaceuticals as a sponsor: 10 trials, 10 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Recruiting | Enrolling by invitation | Active, not recruiting | Completed | All statuses |
|---|---|---|---|---|---|
| Phase 1/2 | 0 | 0 | 1 | 0 | 1 |
| Phase 2 | 0 | 0 | 0 | 3 | 3 |
| Phase 3 | 2 | 1 | 1 | 2 | 6 |
| All phases | 2 | 1 | 2 | 5 | 10 |
Start year
| Start year | Trials |
|---|---|
| 2025 | 3 |
| 2024 | 2 |
| 2021 | 2 |
| 2019 | 2 |
| 2014 | 1 |
Main conditions
Main countries
- United States
- United Kingdom
- Canada
- Argentina
- Belgium
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Alnylam Pharmaceuticals
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-alnylam-pharmaceuticals- Content hash
2a45d0e6f72ab4ea994d40e4b9e7a69399ec7ffc7ae394bfc087fbcad72567ec